TriSalus Life Sciences, Inc. TLSI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.54M+115% | -$9.75M+3.5% | -$10.81M-351% | -$8.29M-91.3% | -$10.38M+21.4% | ||
| $135K-21.5% | $126K-34.7% | $163K-10.4% | $165K-14.9% | $172K-1.7% | ||
| $2.47M+52.6% | $2.2M+29.5% | $3.42M+147% | $1.89M+48.4% | $1.62M+49.2% | ||
| $296K+26.0% | $282K+58.4% | $275K+64.7% | $257K-3.7% | $235K— | ||
| -$1K+99.1% | -$3K+40.0% | —— | —— | -$117K-550% | ||
| -$1.29M-453% | $1.59M+341% | —— | $174K-59.4% | $366K-49.4% | ||
| $701K+515% | -$199K-515% | -$531K-196% | -$355K-167% | $114K-69.0% | ||
| $160K-90.1% | $692K— | $1.51M+175% | -$1.81M+23.1% | $1.62M+632% | ||
| $423K+183% | -$192K— | —— | -$266K-109% | -$511K+46.5% | ||
| $31K-82.1% | $22K-29.0% | $197K+143% | $37K-51.3% | $173K+128% | ||
| -$31K+44.6% | -$27K+32.5% | -$26K+61.8% | -$25K+70.6% | -$56K+34.1% | ||
| -$7.4M-1,003% | $5.15M— | -$2.52M-6.9% | -$700K+94.9% | $820K-79.4% | ||
| -$6.48M-44.0% | -$2.48M+56.5% | -$3.71M+65.8% | -$7.32M+45.5% | -$4.5M+58.6% | ||
| $141K-81.3% | $41K-18.0% | $216K+27.8% | —— | $754K+1,042% | ||
| $0-100% | —— | $40K— | —— | $40K— | ||
| -$141K+80.3% | -$41K+18.0% | -$176K-4.1% | —— | -$714K-982% | ||
| $42.63M— | —— | —— | $22.21M+517% | $0-100% | ||
| $9K-87.3% | $3K-84.2% | $6K-72.7% | $1K-95.2% | $71K+223% | ||
| $263K-49.4% | —— | —— | —— | $520K— | ||
| $42.39M+338% | $277K-90.7% | $82K-98.6% | $20.72M-20.3% | $9.69M+210% | ||
| $35.76M+699% | —— | —— | $13.49M+7.8% | $4.48M+157% | ||
| $1.14M+60.8% | $1.17M— | $971K-25.7% | $848K+89.3% | $709K+23,533% | ||
| $0-100% | —— | —— | $15K+275% | $1K— | ||
| $52K+33.3% | —— | —— | —— | $39K-16.6% | ||
| $296K+26.0% | $282K+58.4% | $275K+64.7% | $257K-3.7% | $235K— | ||
| -$7.4M-1,003% | $5.15M— | -$2.52M-6.9% | -$700K+94.9% | $820K-79.4% | ||
| $3.9M+567% | $0+100% | -$2.79M— | -$477K+94.9% | -$835K-133% | ||
| -$31K+44.6% | -$27K+32.5% | -$26K+61.8% | -$25K+70.6% | -$56K+34.1% | ||
| $423K+183% | -$192K— | —— | -$266K-109% | -$511K+46.5% | ||
| $31K-82.1% | $22K-29.0% | $197K+143% | $37K-51.3% | $173K+128% | ||
| $0-100% | —— | —— | —— | $266K— | ||
| $0-100% | —— | $40K— | —— | $40K— | ||
| $9K-87.3% | $3K-84.2% | $6K-72.7% | $1K-95.2% | $71K+223% | ||
| $263K-49.4% | —— | —— | —— | $520K— | ||
| —— | $101K-6.7% | $101K-6.7% | $101K-6.7% | $101K-6.7% | ||
| $70K-19.5% | $5K— | $43K— | —— | $87K— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $0-100% | —— | —— | —— | $85K— | ||
| $0-100% | —— | —— | —— | $85K— | ||
| -$31K+44.6% | -$27K+32.5% | -$26K+61.8% | -$25K+70.6% | -$56K+34.1% | ||
| $0-100% | —— | —— | —— | $10M— | ||
| $57K— | —— | —— | —— | $0— | ||
| $0+100% | —— | —— | —— | -$366K— | ||
| $0-100% | —— | —— | $15K+275% | $1K— | ||
| -$6.62M-26.0% | -$2.53M+56.1% | -$3.93M+64.4% | -$7.23M+46.4% | -$5.25M+52.0% | ||
| -$6.62M-26.0% | -$2.53M+56.1% | -$3.93M+64.4% | -$7.23M+46.4% | -$5.25M+52.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TriSalus Life Sciences, Inc. generate?
- TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
- What is TriSalus Life Sciences, Inc.'s free cash flow?
- After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
- Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
